MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 63 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $8,895,000 | -26.2% | 11,478,634 | 0.0% | 0.31% | -23.2% |
| Q1 2021 | $12,053,000 | -22.8% | 11,478,634 | 0.0% | 0.41% | -18.5% |
| Q4 2020 | $15,611,000 | +77.5% | 11,478,634 | 0.0% | 0.50% | +65.1% |
| Q3 2020 | $8,793,000 | -0.9% | 11,478,634 | 0.0% | 0.30% | -22.1% |
| Q2 2020 | $8,873,000 | +28.8% | 11,478,634 | 0.0% | 0.39% | -17.0% |
| Q1 2020 | $6,889,000 | -70.2% | 11,478,634 | +12.7% | 0.47% | -64.1% |
| Q4 2019 | $23,127,000 | +260.0% | 10,188,312 | 0.0% | 1.31% | +180.7% |
| Q3 2019 | $6,424,000 | -26.4% | 10,188,312 | 0.0% | 0.47% | -37.9% |
| Q2 2019 | $8,727,000 | -21.4% | 10,188,312 | 0.0% | 0.75% | -41.6% |
| Q1 2019 | $11,105,000 | +230.7% | 10,188,312 | +80.6% | 1.28% | +209.4% |
| Q4 2018 | $3,358,000 | – | 5,642,858 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alliance Wealth Management Group | 400,826 | $465,000 | 0.23% |
| Yellowstone Partners, LLC | 143,914 | $167,000 | 0.09% |
| IFP Advisors, Inc | 251,172 | $291,000 | 0.01% |
| HYMAN CHARLES D | 79,800 | $93,000 | 0.01% |
| Virtu Financial LLC | 106,146 | $123,000 | 0.01% |
| Raymond James Financial Services Advisors, Inc. | 659,890 | $765,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 21,181 | $25,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189,000 | $219,000 | 0.00% |
| BlackRock Inc. | 2,530,508 | $2,935,000 | 0.00% |
| Bank of New York Mellon Corp | 175,325 | $203,000 | 0.00% |